 infusion carboplatin phase studi infus twenty-two cours carboplatin paraplatin bristol-mey evansvil IN cbdca patient advanc cancer continu day infus schedul day day object trial optim dose rate cumul dose treatment schedul dose-limit toxic myelosuppress leukopenia thrombocytopenia optim dose rate infus total cumul dose optim dose rate infus total cumul dose time nadir level leukocyt platelet count day day median time recoveri day day patient grade marrow suppress pattern hematolog toxic infusion cbdca compar bolu schedul clinic advantag infusion schedul cbdca term toxic dose cycl dose intens bolu schedul therapeut advantag infusion schedul prospect compar trial standard bolu schedul infusion schedul cbdca delay pattern thrombocytopenia prolong leukopenia week treatment cycl